VerbatimParliament, as it happens

Diabetes: Insulin

Asked by Tristan OsborneLabourDepartment of Health and Social CareTabled Answered 23 January 2025UIN 24582

The question

To ask the Secretary of State for Health and Social Care, whether he plans to issue new guidance on the use of (a) Novarapid, (b) Insulin flextouch, (c) Insulatard and (d) Levimir for diabetes patients before March 2025.

Answered by Karin Smyth

In late 2024, the Department issued communications on the discontinuation of both Novorapid Flextouch and Insulatard Penfill cartridges to the National Health Service, advising on suitable alternatives. The Department is working with NHS England and clinical experts to develop management advice for healthcare professionals ahead of the discontinuation of Levemir, in December 2026. This will be communicated at the earliest opportunity. There are no plans to issue guidance on Insulin Flextouch.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim